Hamilton Point Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History

Hamilton Point Investment Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.6K	Hold	20,300	–	–	0.01%	171
2026 Q1	$62.3K	Hold	20,300	–	–	0.01%	155
2025 Q4	$72.3K	Hold	20,300	–	–	0.01%	158
2025 Q3	$181K	Hold	20,300	–	–	0.03%	131
2025 Q2	$187K	Hold	20,300	–	–	0.03%	129
2025 Q1	$174K	Hold	20,300	–	–	0.03%	123
2024 Q4	$218K	Hold	20,300	–	–	0.04%	119
2024 Q3	$115K	Hold	20,300	–	–	0.02%	130
2024 Q2	$85.7K	Hold	20,300	–	–	0.02%	123
2024 Q1	$103K	Hold	20,300	–	–	0.02%	125
2023 Q4	$189K	Hold	20,300	–	–	0.04%	122
2023 Q3	$133K	Hold	20,300	–	–	0.03%	118
2023 Q2	$165K	Hold	20,300	–	–	0.04%	120
2023 Q1	$174K	Buy	+20,300	New	+$203K	0.04%	117

Other funds holding AVXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hamilton Point Investment Advisors's AVXL Position: Q2 2026 in Review

Hamilton Point Investment Advisors held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 20,300 shares worth $52.6K. The position accounts for 0.01% of the portfolio, ranked #171.

Hamilton Point Investment Advisors first reported a position in AVXL in Q1 2023 and has held it in 14 quarters since. The position peaked at $218K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

Hamilton Point Investment Advisors held 20,300 shares of Anavex Life Sciences worth $52.6K as of Q2 2026.
Hamilton Point Investment Advisors left its Anavex Life Sciences share count unchanged in Q2 2026.
Anavex Life Sciences made up 0.01% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #171 holding.
Hamilton Point Investment Advisors first reported a position in Anavex Life Sciences in Q1 2023 and has held it in 14 quarters since.
Hamilton Point Investment Advisors's Anavex Life Sciences position peaked at $218K in Q4 2024.
179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.